Dr Ronan Lordan

Available to discuss new collaborations, science outreach or speaking opportunities. Feel free to make contact via email or twitter.



Institute for Translational Medicine and Therapeutics

Perelman School of Medicine, University of Pennsylvania



Modulation of the immune response to SARS-CoV-2 vaccination by NSAIDs.


Journal article


C. Skarke, R. Lordan, Kayla Barekat, A. Naik, D. Mathew, T. Ohtani, A. Greenplate, Gregory R Grant, N. Lahens, S. Gouma, Elizabeth Troisi, Arjun Sengupta, A. Weljie, Wenzhao Meng, E. L. Luning Prak, Kendall A. Lundgreen, Paul Bates, H. Meng, G. FitzGerald
Journal of Pharmacology and Experimental Therapeutics, 2023

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
Skarke, C., Lordan, R., Barekat, K., Naik, A., Mathew, D., Ohtani, T., … FitzGerald, G. (2023). Modulation of the immune response to SARS-CoV-2 vaccination by NSAIDs. Journal of Pharmacology and Experimental Therapeutics.


Chicago/Turabian   Click to copy
Skarke, C., R. Lordan, Kayla Barekat, A. Naik, D. Mathew, T. Ohtani, A. Greenplate, et al. “Modulation of the Immune Response to SARS-CoV-2 Vaccination by NSAIDs.” Journal of Pharmacology and Experimental Therapeutics (2023).


MLA   Click to copy
Skarke, C., et al. “Modulation of the Immune Response to SARS-CoV-2 Vaccination by NSAIDs.” Journal of Pharmacology and Experimental Therapeutics, 2023.


BibTeX   Click to copy

@article{c2023a,
  title = {Modulation of the immune response to SARS-CoV-2 vaccination by NSAIDs.},
  year = {2023},
  journal = {Journal of Pharmacology and Experimental Therapeutics},
  author = {Skarke, C. and Lordan, R. and Barekat, Kayla and Naik, A. and Mathew, D. and Ohtani, T. and Greenplate, A. and Grant, Gregory R and Lahens, N. and Gouma, S. and Troisi, Elizabeth and Sengupta, Arjun and Weljie, A. and Meng, Wenzhao and Prak, E. L. Luning and Lundgreen, Kendall A. and Bates, Paul and Meng, H. and FitzGerald, G.}
}

Abstract

Evidence is scarce to guide the use of nonsteroidal anti-inflammatory drugs (NSAIDs) to mitigate SARS-CoV-2 vaccine related adverse effects, given the possibility of blunting the desired immune response. In this pilot study, we deeply phenotyped a small number of volunteers who did or did not take NSAIDs concomitant with SARS-CoV-2 immunizations to seek initial information on the immune response. A SARS-CoV-2 vaccine specific RBD-IgG antibody response and efficacy in the evoked neutralization titers were evident irrespective of concomitant NSAID consumption. Given the sample size, only a large and consistent signal of immunomodulation would have been detectable, and this was not apparent. However, the information gathered may inform the design of a definitive clinical trial. Here, we report a series of divergent omics signals that invite additional hypotheses testing. Significance Statement A SARS-CoV-2 vaccine specific immune response was evident irrespective of concomitant NSAID consumption in a clinical pilot study of small sample size.


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in